Search research articles
Contact Us
Filters
Showing results (11-20 of 66) with videos related to
Page
of 7
Sort By:
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
July 22, 2017
Biomarkers for the early detection of relapses in metastatic colorectal cancers
Gabriela Chereches, Otilia Barbos, Rares Buiga, et al.
Medicine and Pharmacy Reports
|
September 5, 2024
Next-generation sequencing as a valuable tool for mutational spectrum in advanced-stage NSCLC patients
Ioana Iurca, Ecaterina Isakescu, Laura Ancuta Pop, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
December 24, 2014
Hepatocellular carcinoma: insights in the biological treatment beyond sorafenib
Bogdan Gafton, Vlad Porumb, Simona Ungurianu, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
August 30, 2016
A phase II single institution single arm prospective study with paclitaxel, ifosfamide and cisplatin (TIP) as first-line chemotherapy in high-risk germ cell tumor patients with more than ten years follow-up and retrospective correlation with ERCC1, Topoisomerase 1, 2A, p53 and HER-2 expression
Cristina Ligia Cebotaru, Nicoleta Zenovia Antone, Elena Diana Olteanu, et al.
Biomolecules & Biomedicine
|
August 25, 2023
MicroRNAs expression profile in chemotherapy-induced cardiotoxicity in NSCLC using a co-culture model
Mihai Romitan, Oana Zanoaga, Liviuta Budisan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2006
Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer
Mary E R O'Brien, Tudor-Eliade Ciuleanu, Hristo Tsekov, et al.
British Journal of Cancer
|
August 4, 2017
Randomised Phase 2 study of maintenance linsitinib (OSI-906) in combination with erlotinib compared with placebo plus erlotinib after platinum-based chemotherapy in patients with advanced non-small cell lung cancer
Tudor-Eliade Ciuleanu, Samreen Ahmed, Joo-Hang Kim, et al.
Current Issues in Molecular Biology
|
September 29, 2025
Serum TNF -α, IL-10 and IL-2 Trajectories and Outcomes in NSCLC and Melanoma Under Anti-PD-1 Therapy: Longitudinal Real-World Evidence from a Single Center
Alina Miruna Grecea-Balaj, Olga Soritau, Ioana Brie, et al.
Oncotarget
|
September 11, 2020
A multicenter, single-arm, basket design, phase II study of NC-6004 plus gemcitabine in patients with advanced unresectable lung, biliary tract, or bladder cancer
Simona Ruxandra Volovat, Tudor-Eliade Ciuleanu, Piotr Koralewski, et al.
International Journal of Molecular Sciences
|
April 17, 2025
Prospective Upfront Next-Generation Sequencing for Advanced Non-Small Cell Lung Cancer: Real-World Outcomes from the Ion Chiricuță Oncology Institute
Alexandra Cristina Preda, Nicolae Todor, Bogdan Cârlan, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 66) with videos related to
Sort By:
Page
of 7
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
July 22, 2017
Biomarkers for the early detection of relapses in metastatic colorectal cancers
Gabriela Chereches, Otilia Barbos, Rares Buiga, et al.
Medicine and Pharmacy Reports
|
September 5, 2024
Next-generation sequencing as a valuable tool for mutational spectrum in advanced-stage NSCLC patients
Ioana Iurca, Ecaterina Isakescu, Laura Ancuta Pop, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
December 24, 2014
Hepatocellular carcinoma: insights in the biological treatment beyond sorafenib
Bogdan Gafton, Vlad Porumb, Simona Ungurianu, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
August 30, 2016
A phase II single institution single arm prospective study with paclitaxel, ifosfamide and cisplatin (TIP) as first-line chemotherapy in high-risk germ cell tumor patients with more than ten years follow-up and retrospective correlation with ERCC1, Topoisomerase 1, 2A, p53 and HER-2 expression
Cristina Ligia Cebotaru, Nicoleta Zenovia Antone, Elena Diana Olteanu, et al.
Biomolecules & Biomedicine
|
August 25, 2023
MicroRNAs expression profile in chemotherapy-induced cardiotoxicity in NSCLC using a co-culture model
Mihai Romitan, Oana Zanoaga, Liviuta Budisan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2006
Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer
Mary E R O'Brien, Tudor-Eliade Ciuleanu, Hristo Tsekov, et al.
British Journal of Cancer
|
August 4, 2017
Randomised Phase 2 study of maintenance linsitinib (OSI-906) in combination with erlotinib compared with placebo plus erlotinib after platinum-based chemotherapy in patients with advanced non-small cell lung cancer
Tudor-Eliade Ciuleanu, Samreen Ahmed, Joo-Hang Kim, et al.
Current Issues in Molecular Biology
|
September 29, 2025
Serum TNF -α, IL-10 and IL-2 Trajectories and Outcomes in NSCLC and Melanoma Under Anti-PD-1 Therapy: Longitudinal Real-World Evidence from a Single Center
Alina Miruna Grecea-Balaj, Olga Soritau, Ioana Brie, et al.
Oncotarget
|
September 11, 2020
A multicenter, single-arm, basket design, phase II study of NC-6004 plus gemcitabine in patients with advanced unresectable lung, biliary tract, or bladder cancer
Simona Ruxandra Volovat, Tudor-Eliade Ciuleanu, Piotr Koralewski, et al.
International Journal of Molecular Sciences
|
April 17, 2025
Prospective Upfront Next-Generation Sequencing for Advanced Non-Small Cell Lung Cancer: Real-World Outcomes from the Ion Chiricuță Oncology Institute
Alexandra Cristina Preda, Nicolae Todor, Bogdan Cârlan, et al.
Page
of 7